CompletedPhase 1/2

Brain Networks Implicated in Lifelong Premature Ejaculation Patients

Spain128 participantsStarted 2021-02-02

Plain-language summary

Using Brain Mapping and Cognitive ERPs, the investigatos have searched for a Brain Networks involved during Inhibitory Control in Lifelong Premature Ejaculation (LPE) participants. The investigators have designed a clinical trial comparing placebo with tDCS and blacebo group against Dapoxetine, studying the effects on LPE, as well as side effects and their medium and long-term duration.

Who can participate

Age range30 Years – 70 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * To be over 18 years old and less than 70 years * Best-practice diagnosed Longlife Premature ejaculation * Diagnosed since at least one years prior to enrollment. * No use drugs or medicines Exclusion Criteria: * Serious visual and hearing loss * Brain injury following cranial trauma * Other neurological disorders like Parkinson, ME, headache, etc. * Birth trauma * Mental retardation

What they're measuring

Wavelet Changes define Brain Biomarker of LPE

Timeframe: 1 month

EEG coherence comparing Dapoxetine against tRNS

Timeframe: 2-3 months

Adverse events comparing Dapoxetine against tRNS

Timeframe: 2-3 months

Trial details

NCT IDNCT04850703

SponsorMoises Domingo

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-05-21

View on ClinicalTrials.gov More Premature Ejaculation trials